跳至主要内容
临床试验/NCT04424706
NCT04424706Unknown不适用

The Effect and Mechanism of MMP-9 in Inducing Atherosclerosis in Type 2 Diabetes

Majianhua1 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2020年6月30日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
180
试验地点
1
主要终点
total MMP-9 levels

研究概览

简要总结

The study will assess the serum expression of MMP-9 in normal people, type 2 diabetic patients and type 2 diabetic patients with atherosclerosis.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • volunteer to participate and be able to sign informed consent prior to the trial.
  • patients with type 2 diabetes, aged 18-60 years old, meeting WHO1999 diagnostic criteria, have not used any drugs.
  • The patients have completed carotid ultrasound during hospitalization.

排除标准

  • patients with any antidiabetic drugs.
  • impaired liver and kidney function with ALT 2.5 times higher than the upper limit of normal value; Serum creatinine was 1.3 times higher than the upper limit of normal.
  • drug abuse and alcohol dependence in the past 5 years.
  • systemic hormone therapy was used in the last three months.
  • patients with infection and stress within 4 weeks.
  • any other obvious conditions or associated diseases determined by the researcher: such as severe cardiopulmonary diseases, endocrine diseases, neurological diseases, tumors and other diseases, other pancreatic diseases, history of mental diseases.

结局指标

主要结局

total MMP-9 levels

时间窗: 6 months

the different group of total MMP-9 levels

次要结局

未报告次要终点

研究者

发起方
Majianhua
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Majianhua

Head of Department of Endocrinology

Nanjing First Hospital, Nanjing Medical University

研究点 (1)

Loading locations...

相似试验